{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T17:15:07Z","timestamp":1776791707172,"version":"3.51.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary hyperparathyroidism (pHPT) is infrequently associated with calcium-containing kidney stones, despite hypercalciuria. Parathyroidectomy (PTX) is the only curative treatment of the metabolic disorder and is indirectly regarded as prophylaxis of recurrence of stone formation. The aim of the systematic review was to evaluate the impact of PTX on stone recurrence and to identify possible predictors of recurrent stone formation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following PRISMA guidelines, a\u00a0systematic PubMed search was conducted through April 2025. Eligible studies including adults with successfully surgically treated pHPT, documented nephrolithiasis and a\u00a0follow-up of at least 12\u00a0months were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 13 studies (2 prospective cohorts, 10\u00a0retrospective cohorts, 1 randomized controlled trial, RCT) comprising more than 8000 patients met the inclusion criteria. After PTX, recurrence rates in prospective studies ranged from 0\u201330% among stone formers, while retrospective series showed a\u00a0wider range (between 0% and 58%). Registry data indicated that in patients with a\u00a0history of nephrolithiasis, the recurrence risk seems higher shortly after PTX compared with conservative management of pHPT but decreases substantially with each subsequent year. In patients without a\u00a0stone history, de novo stone formation was rare; in the RCT, recurrence occurred in 0% after PTX versus 4% under observation. Consistent predictors of recurrence included persistent hypercalciuria, multiple preoperative stone episodes, hypocitraturia, elevated body mass index, and male sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The use of PTX significantly reduces the long-term risk of stone recurrence but does not eliminate it entirely. In patients with a\u00a0history of nephrolithiasis, short-term risk may be elevated after PTX but declines markedly over time.<\/jats:p>\n                    <jats:p>Individualized follow-up including regular assessment of serum calcium, parathyroid hormone, renal function, and 24\u2011h urinary parameters, together with preventive measures where indicated, such as adequate fluid intake, dietary counselling, potassium citrate or thiazide therapy, is recommended, particularly in patients with persistent risk factors.<\/jats:p>\n                    <jats:p>Decisions regarding surgical treatment of existing kidney stones should be individualized based on stone size, location, symptoms, infection risk as well as the overall patient risk profile and life expectancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00508-026-02733-9","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:38:30Z","timestamp":1774345110000},"page":"225-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of parathyroidectomy on stone recurrence in primary hyperparathyroidism"],"prefix":"10.1007","volume":"138","author":[{"given":"Victoria","family":"Jahrreiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozan","family":"Yurdakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Veser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8424-9492","authenticated-orcid":false,"given":"Christian","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"4","key":"2733_CR1","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1210\/jc.2014-3708","volume":"100","author":"C Cipriani","year":"2015","unstructured":"Cipriani\u00a0C, Biamonte\u00a0F, Costa\u00a0AG, Zhang\u00a0C, Biondi\u00a0P, Diacinti\u00a0D, et\u00a0al. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J\u00a0Clin Endocrinol Metab. 2015;100(4):1309\u201315.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2733_CR2","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1530\/EJE-16-0430","volume":"176","author":"C Verdelli","year":"2017","unstructured":"Verdelli\u00a0C, Corbetta\u00a0S. MECHANISMS IN ENDOCRINOLOGY: Kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects. Eur J Endocrinol. 2017;176(1):R39\u2013R52.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2733_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.2214\/AJR.07.3160","volume":"191","author":"JM Suh","year":"2008","unstructured":"Suh\u00a0JM, Cronan\u00a0JJ, Monchik\u00a0JM. Primary hyperparathyroidism: is there an increased prevalence of renal stone disease? AJR Am J Roentgenol. 2008;191(3):908\u201311.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"2733_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4103\/2230-8210.93745","volume":"16","author":"AR Lila","year":"2012","unstructured":"Lila\u00a0AR, Sarathi\u00a0V, Jagtap\u00a0V, Bandgar\u00a0T, Menon\u00a0PS, Shah\u00a0NS. Renal manifestations of primary hyperparathyroidism. Indian J Endocrinol Metab. 2012;16(2):258\u201362.","journal-title":"Indian J Endocrinol Metab"},{"key":"2733_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.8","volume":"2","author":"SR Khan","year":"2016","unstructured":"Khan\u00a0SR, Pearle\u00a0MS, Robertson\u00a0WG, Gambaro\u00a0G, Canales\u00a0BK, Doizi\u00a0S, et\u00a0al. Kidney stones. Nat Rev Dis Primers. 2016;2:16008.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2733_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","volume":"28","author":"AA Khan","year":"2017","unstructured":"Khan\u00a0AA, Hanley\u00a0DA, Rizzoli\u00a0R, Bollerslev\u00a0J, Young\u00a0JE, Rejnmark\u00a0L, et\u00a0al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28(1):1\u201319.","journal-title":"Osteoporos Int"},{"issue":"11","key":"2733_CR7","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","volume":"37","author":"JP Bilezikian","year":"2022","unstructured":"Bilezikian\u00a0JP, Khan\u00a0AA, Silverberg\u00a0SJ, Fuleihan\u00a0GE, Marcocci\u00a0C, Minisola\u00a0S, et\u00a0al. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J\u00a0Bone Miner Res. 2022;37(11):2293\u2013314.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2733_CR8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm\u00a0SM, Wang\u00a0TS, Ruan\u00a0DT, Lee\u00a0JA, Asa\u00a0SL, Duh\u00a0QY, et\u00a0al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016;151(10):959\u201368.","journal-title":"JAMA Surg"},{"issue":"7368","key":"2733_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/bmj.325.7368.807","volume":"325","author":"CL Mollerup","year":"2002","unstructured":"Mollerup\u00a0CL, Vestergaard\u00a0P, Fr\u00f8kjaer\u00a0VG, Mosekilde\u00a0L, Christiansen\u00a0P, Blichert-Toft\u00a0M. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. Bmj. 2002;325(7368):807.","journal-title":"Bmj"},{"key":"2733_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page\u00a0MJ, McKenzie\u00a0JE, Bossuyt\u00a0PM, Boutron\u00a0I, Hoffmann\u00a0TC, Mulrow\u00a0CD, et\u00a0al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71.","journal-title":"Bmj"},{"issue":"17","key":"2733_CR11","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","volume":"341","author":"SJ Silverberg","year":"1999","unstructured":"Silverberg\u00a0SJ, Shane\u00a0E, Jacobs\u00a0TP, Siris\u00a0E, Bilezikian\u00a0JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N\u00a0Engl J Med. 1999;341(17):1249\u201355.","journal-title":"N Engl J Med"},{"issue":"2","key":"2733_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/PL00013175","volume":"23","author":"CL Mollerup","year":"1999","unstructured":"Mollerup\u00a0CL, Lindewald\u00a0H. Renal stones and primary hyperparathyroidism: natural history of renal stone disease after successful parathyroidectomy. World J Surg. 1999;23(2):173\u20135.","journal-title":"World J Surg"},{"issue":"11","key":"2733_CR13","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1210\/jc.2004-0028","volume":"89","author":"DS Rao","year":"2004","unstructured":"Rao\u00a0DS, Phillips\u00a0ER, Divine\u00a0GW, Talpos\u00a0GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J\u00a0Clin Endocrinol Metab. 2004;89(11):5415\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2733_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1308\/003588413X13629960048712","volume":"95","author":"C Rowlands","year":"2013","unstructured":"Rowlands\u00a0C, Zyada\u00a0A, Zouwail\u00a0S, Joshi\u00a0H, Stechman\u00a0MJ, Scott-Coombes\u00a0DM. Recurrent urolithiasis following parathyroidectomy for primary hyperparathyroidism. Ann R Coll Surg Engl. 2013;95(7):523\u20138.","journal-title":"Ann R Coll Surg Engl"},{"issue":"3","key":"2733_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.surg.2011.07.039","volume":"151","author":"MD Sorensen","year":"2012","unstructured":"Sorensen\u00a0MD, Duh\u00a0QY, Grogan\u00a0RH, Tran\u00a0TC, Stoller\u00a0ML. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism. Surgery. 2012;151(3):477\u201383.","journal-title":"Surgery"},{"issue":"1","key":"2733_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jamcollsurg.2020.04.015","volume":"231","author":"AK Islam","year":"2020","unstructured":"Islam\u00a0AK, Holt\u00a0S, Reisch\u00a0J, Nwariaku\u00a0F, Antonelli\u00a0J, Maalouf\u00a0NM. What Predicts Recurrent Kidney Stone after Parathyroidectomy in Patients with Primary Hyperparathyroidism? J\u00a0Am Coll Surg. 2020;231(1):74\u201382.","journal-title":"J Am Coll Surg"},{"issue":"4","key":"2733_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00240-020-01239-x","volume":"49","author":"PY Charles","year":"2021","unstructured":"Charles\u00a0PY, Letavernier\u00a0E, P\u00e9ri\u00e9\u00a0S, Gauth\u00e9\u00a0M, Daudon\u00a0M, Haymann\u00a0JP. Effect of parathyroidectomy on renal stone recurrence. Urolithiasis. 2021;49(4):327\u201334.","journal-title":"Urolithiasis"},{"issue":"7414","key":"2733_CR18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/bmj.327.7414.530","volume":"327","author":"P Vestergaard","year":"2003","unstructured":"Vestergaard\u00a0P, Mosekilde\u00a0L. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. Bmj. 2003;327(7414):530\u20134.","journal-title":"Bmj"},{"issue":"6","key":"2733_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.15396","volume":"5","author":"KF Axelsson","year":"2022","unstructured":"Axelsson\u00a0KF, Wallander\u00a0M, Johansson\u00a0H, Harvey\u00a0NC, Vandenput\u00a0L, McCloskey\u00a0E, et\u00a0al. Analysis of Comorbidities, Clinical Outcomes, and Parathyroidectomy in Adults With Primary Hyperparathyroidism. JAMA Netw Open. 2022;5(6)e2215396.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2733_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.surg.2021.03.077","volume":"171","author":"SY Huang","year":"2022","unstructured":"Huang\u00a0SY, Burchette\u00a0R, Chung\u00a0J, Haigh\u00a0PI. Parathyroidectomy for nephrolithiasis in primary hyperparathyroidism: Beneficial but not a panacea. Surgery. 2022;171(1):29\u201334.","journal-title":"Surgery"},{"issue":"9","key":"2733_CR21","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.eprac.2021.06.004","volume":"27","author":"CD Seib","year":"2021","unstructured":"Seib\u00a0CD, Ganesan\u00a0C, Arnow\u00a0KD, Suh\u00a0I, Pao\u00a0AC, Leppert\u00a0JT, et\u00a0al. Association of Parathyroidectomy With 5\u2011Year Clinically Significant Kidney Stone Events in Patients With Primary Hyperparathyroidism. Endocr Pract. 2021;27(9):948\u201355.","journal-title":"Endocr Pract"},{"issue":"7","key":"2733_CR22","doi-asserted-by":"publisher","first-page":"e2801","DOI":"10.1210\/clinem\/dgac193","volume":"107","author":"CD Seib","year":"2022","unstructured":"Seib\u00a0CD, Ganesan\u00a0C, Arnow\u00a0KD, Pao\u00a0AC, Leppert\u00a0JT, Barreto\u00a0NB, et\u00a0al. Kidney Stone Events Following Parathyroidectomy vs Nonoperative Management for Primary Hyperparathyroidism. J\u00a0Clin Endocrinol Metab. 2022;107(7):e2801\u2013e11.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2733_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/1754-9485.13605","volume":"68","author":"M Kandasamy","year":"2024","unstructured":"Kandasamy\u00a0M, Chan\u00a0M, Xiang\u00a0H, Chan\u00a0L, Ridley\u00a0L. Comparison of diagnostic accuracy of ultra low-dose computed tomography and X\u2011ray of the kidneys, ureters and bladder for urolithiasis in the follow-up setting. J\u00a0Med Imaging Radiat Oncol. 2024;68(2):132\u201340.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"2","key":"2733_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00423-016-1520-2","volume":"402","author":"A Selberherr","year":"2017","unstructured":"Selberherr\u00a0A, H\u00f6rmann\u00a0M, Prager\u00a0G, Riss\u00a0P, Scheuba\u00a0C, Niederle\u00a0B. \u201cSilent\u201d kidney stones in \u201casymptomatic\u201d primary hyperparathyroidism\u2011a comparison of multidetector computed tomography and ultrasound. Langenbecks Arch Surg. 2017;402(2):289\u201393.","journal-title":"Langenbecks Arch Surg"},{"key":"2733_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.amjsurg.2024.03.007","volume":"231","author":"T Zabolotniuk","year":"2024","unstructured":"Zabolotniuk\u00a0T, Guo\u00a0M, Kwon\u00a0M, Watanabe\u00a0A, Teichman\u00a0JMH, Wiseman\u00a0SM. Screening for asymptomatic nephrolithiasis in primary hyperparathyroidism patients is warranted. Am J Surg. 2024;231:91\u20135.","journal-title":"Am J Surg"},{"issue":"1","key":"2733_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.urology.2014.01.016","volume":"84","author":"MA Elkoushy","year":"2014","unstructured":"Elkoushy\u00a0MA, Yu\u00a0AX, Tabah\u00a0R, Payne\u00a0RJ, Dragomir\u00a0A, Andonian\u00a0S. Determinants of urolithiasis before and after parathyroidectomy in patients with primary hyperparathyroidism. Urology. 2014;84(1):22\u20136.","journal-title":"Urology"},{"issue":"3","key":"2733_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.surg.2011.07.039","volume":"151","author":"MD Sorensen","year":"2012","unstructured":"Sorensen\u00a0MD, Duh\u00a0QY, Grogan\u00a0RH, Tran\u00a0TC, Stoller\u00a0ML. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism. Surgery. 2012;151(3):477\u201383.","journal-title":"Surgery"},{"issue":"1","key":"2733_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.surg.2021.03.073","volume":"171","author":"MS Lui","year":"2022","unstructured":"Lui\u00a0MS, Fisher\u00a0JC, Underwood\u00a0HJ, Patel\u00a0KN, Ogilvie\u00a0JB. Stones left unturned: Missed opportunities to diagnose primary hyperparathyroidism in patients with nephrolithiasis. Surgery. 2022;171(1):23\u20138.","journal-title":"Surgery"},{"issue":"9","key":"2733_CR29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1001\/jamasurg.2020.2423","volume":"155","author":"C Ganesan","year":"2020","unstructured":"Ganesan\u00a0C, Weia\u00a0B, Thomas\u00a0IC, Song\u00a0S, Velaer\u00a0K, Seib\u00a0CD, et\u00a0al. Analysis of Primary Hyperparathyroidism Screening Among US Veterans With Kidney Stones. JAMA Surg. 2020;155(9):861\u20138.","journal-title":"JAMA Surg"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-026-02733-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-026-02733-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-026-02733-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:03:28Z","timestamp":1776755008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-026-02733-9"}},"subtitle":["A\u00a0systematic review"],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":29,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2733"],"URL":"https:\/\/doi.org\/10.1007\/s00508-026-02733-9","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.\u00a0Jahrreiss, O.\u00a0Yurdakul, J.\u00a0Veser and C.\u00a0Seitz declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}